Breaking news from “The Pink Sheet” DAILY
Executive Summary
Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including FDA's Jan. 7 approval of American Pharmaceutical Partners' nanoparticle albumin-bound paclitaxel formulation Abraxane, and DTC ads for Pfizer's COX-2 inhibitor Celebrex. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...